San Vittore Olona, Italy

Luca Piacenza

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luca Piacenza. Retrieved from https://idiyas.com/inventor/luca-piacenza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Luca Piacenza

Introduction

Luca Piacenza is a notable inventor based in San Vittore Olona, Italy. He has made significant contributions to the field of biotechnology, particularly in the production of taxanes, which are important compounds in cancer treatment.

Latest Patents

Luca Piacenza holds a patent for "Paclitaxel production by actinomycetes." This invention relates to microorganisms that produce taxanes, such as paclitaxel, and outlines the procedure for isolating these microorganisms from plants. The patent emphasizes the use of Actinomycetes group microorganisms, particularly those belonging to the genera Streptomyces, Actinoplanes, Nocardiopsis, Micromonospora, Actinomadura, and Kitasatosporia. A particularly preferred microorganism mentioned in the patent is Kitasatosporia sp. CECT 4991. He has 1 patent to his name.

Career Highlights

Luca Piacenza is currently associated with Pharmacia & Upjohn, where he continues to innovate in the field of microbiology and biotechnology. His work focuses on harnessing the potential of microorganisms for pharmaceutical applications.

Collaborations

Luca has collaborated with several professionals in his field, including Umberto Breme and Marinella Caruso. These collaborations have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Luca Piacenza's work in the production of paclitaxel through actinomycetes showcases his innovative spirit and dedication to advancing biotechnology. His contributions are significant in the ongoing fight against cancer, highlighting the importance of research and development in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…